Eurolung风险评分与肺癌根治性切除术后长期生存相关
该研究纳入1359例接受解剖性肺切除的肺癌患者,计算Eurolung2聚合评分并分析其与长期生存的关系。中位随访802天,5年总生存率随评分等级升高而下降(A级75%、B级52%、C级29%、D级27%,P<.0001)。校正pT和pN分期后,Eurolung评分仍与总生存(HR 1.19,P<.0001)和疾病特异性生存(HR 1.09,P=.005)独立相关。
要点
- Eurolung评分越高,肺癌术后5年总生存率越低。
- 评分可区分pT1或pT>1患者的3年总生存。
- 校正分期后评分仍独立预测总生存和疾病特异性生存。
核心结论
- Eurolung聚合评分与肺癌根治性切除术后的长期生存相关。
研究设计与样本
- 回顾性分析1359例连续接受解剖性肺切除的患者(1136例肺叶切除、103例全肺切除、120例肺段切除,2014-2018年),计算Eurolung2评分,中位随访802天。
主要发现
- 按Eurolung评分分为4级:A级0-2.5分(52%)、B级3-5分(33%)、C级5.5-6.5分(8%)、D级7-11.5分(7%)。
- 5年总生存率随等级升高而下降:A级75%、B级52%、C级29%、D级27%(log rank P<.0001)。
- 评分可分层pT1(P<.0001)或pT>1(P<.0001)患者的3年总生存。
- 不同等级与pN0(P<.0001)和阳性淋巴结(P=.0005)患者的长期总死亡风险递增相关。
- 校正pT和pN分期后,Eurolung聚合评分仍与总生存(HR 1.19,P<.0001)和疾病特异性生存(HR 1.09,P=.005)显著相关。
临床怎么用
- Eurolung评分可用于高危肺癌患者根治性治疗决策的多学科讨论和共享决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The study objective was to verify whether the Eurolung score was associated with long-term prognosis after lung cancer resection. METHODS: A total of 1359 consecutive patients undergoing anatomic lung resection (1136 lobectomies, 103 pneumonectomies, 120 segmentectomies) (2014-2018) were analyzed. The parsimonious aggregate Eurolung2 score was calculated for each patient. Median follow-up was 802 days. Survival distribution was estimated by the Kaplan-Meier method. Cox proportional hazard regression and competing risk regression analyses were used to assess the independent association of Eurolung with overall and disease-specific survival. RESULTS: Patients were grouped into 4 classes according to their Eurolung scores (A 0-2.5, B 3-5, C 5.5-6.5, D 7-11.5). Most patients were in class A (52%) and B (33%), 8% were in class C, and 7% were in class D. Five-year overall survival decreased across the categories (A: 75%; B: 52%; C: 29%; D: 27%, log rank P < .0001). The score stratified the 3-year overall survival in patients with pT1 (P < .0001) or pT>1 (P < .0001). In addition, the different classes were associated with incremental risk of long-term overall mortality in patients with pN0 (P < .0001) and positive nodes (P = .0005). Cox proportional hazard regression and competing regression analyses showed that Eurolung aggregate score remained significantly associated with overall (hazard ratio, 1.19; P < .0001) and disease-specific survival after adjusting for pT and pN stage (hazard ratio, 1.09; P = .005). CONCLUSIONS: Eurolung aggregate score was associated with long-term survival after curative resection for cancer. This information may be valuable to inform the shared decision-making process and the multidisciplinary team discussion assisting in the selection of the most appropriate curative treatment in high-risk patients.
引用
- Brunelli A, Chaudhuri N, Kefaloyannis M, et al. Eurolung risk score is associated with long-term survival after curative resection for lung cancer. J Thorac Cardiovasc Surg. 2020. PMID: 32948299. doi:10.1016/j.jtcvs.2020.06.151
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。